Berry Genomics Co.,Ltd (SHE:000710)
10.60
0.00 (0.00%)
May 19, 2026, 10:25 AM CST
Berry Genomics Co.,Ltd Revenue
Berry Genomics Co.,Ltd had revenue of 210.22M CNY in the quarter ending March 31, 2026, a decrease of -3.46%. This brings the company's revenue in the last twelve months to 922.27M, down -9.26% year-over-year. In the year 2025, Berry Genomics Co.,Ltd had annual revenue of 929.82M, down -13.76%.
Revenue (ttm)
922.27M
Revenue Growth
-9.26%
P/S Ratio
4.06
Revenue / Employee
657.83K
Employees
1,402
Market Cap
3.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 929.82M | -148.35M | -13.76% |
| Dec 31, 2024 | 1.08B | -73.25M | -6.36% |
| Dec 31, 2023 | 1.15B | -216.59M | -15.83% |
| Jan 1, 2023 | 1.37B | -54.17M | -3.81% |
| Jan 1, 2022 | 1.42B | -118.20M | -7.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maccura Biotechnology Co.Ltd | 2.14B |
| Medicalsystem Biotechnology | 1.54B |
| Shanghai Labway Clinical Laboratory | 1.38B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Amoy Diagnostics | 1.19B |
| Thalys Medical Technology Group | 971.32M |
| SMO ClinPlus CO.,LTD. | 860.07M |
| Guangdong Hybribio Biotech | 669.64M |